Barclays analyst Luke Sergott downgraded Illumina (NASDAQ: ILMN) from Equalweight to Underweight with a price target of $100.00 (from $130.00).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades

TD Cowen cuts rating on Illumina stock to holdFebruary 7, 2025 11:14 AM RBC on Illumina (ILMN): 'A Stock To Own For Multiple Investment Strategies'; PT Lowered to $247February 7, 2025 11:12 AM Illumina (ILMN) PT Maintained at JPMorganFebruary 7, 2025 9:07 AM TD Cowen Downgrades Illumina (ILMN) to HoldFebruary 7, 2025 7:38 AM Illumina (ILMN) PT Lowered to $127 at BairdFebruary 7, 2025 7:29 AM Illumina (ILMN) PT Lowered to $135 at Canaccord GenuityFebruary 7, 2025 6:38 AM Illumina (ILMN) PT Lowered to $150 at Leerink PartnersFebruary 7, 2025 6:21 AM Illumina forecasts 2025 revenue largely below estimatesFebruary 6, 2025 4:42 PM Form 8-K ILLUMINA, INC. For: Feb 06February 6, 2025 4:11 PM Illumina (ILMN) Tops Q4 EPS by 3c, provides guidanceFebruary 6, 2025 4:10 PM Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024February 6, 2025 4:05 PM